On a Wednesday night in Manhattan, the Theater District appears to be a thriving business from the outside, with bright marquees and moving lines. The Broadway League has been releasing revenue data that have broken records. A comeback is described in the headlines. The investors, on the other hand, frequently provide a different picture, one in which they see a performance play to respectable houses for months without being able to recoup the initial investment.
Since theaters reopened after the pandemic, less than 10% of new Broadway musicals have recovered their initial investment. That is a shocking figure that doesn’t match well with the story of the Broadway revival. The entire amount of revenue is actual. There is also an actual recoupment failure. In order to comprehend why both of these statements are true at the same time, one must examine the genuine costs associated with launching and maintaining a Broadway musical.
Before a single ticket is sold, a new musical’s capitalization usually ranges from $20 million to $25 million. This includes planning, rehearsals, technical production, marketing, and a show’s physical setup. The weekly operating expenditures, which include union wages, venue fees, continuing marketing, royalties, and everything else needed to keep a play alive, can reach $800,000 or more once the curtain rises. In order to cover the outflow and reduce the initial capitalization, a concert must sell a huge number of seats at the current average ticket price of $127. Even for critically lauded productions, the math is harsh and doesn’t ease much.
Consumer behavior has changed in ways that exacerbate the issue. Before the pandemic, producers could rely on advance sales—blocks of tickets bought months in advance by group buyers, season subscribers, and travelers making prior plans—to stabilize cash flow in the first few weeks of a play. That pattern has significantly deteriorated.
Shows increasingly operate closer to the financial edge for longer before they can assess whether or not they have a true audience since audiences book later, frequently closer to the performance date. In order to survive their early weeks on advance sales, shows now need to hope that word-of-mouth grows more quickly than their bank account drains.
Broadway has historically relied primarily on tourist attendance, which has returned to pre-pandemic levels more slowly than domestic theatergoers. Additionally, visitors are choosing differently how to spend their entertainment dollars. Concerts, comedies, sporting events, and immersive experiences have all significantly increased competition. Live theater now receives a lesser portion of discretionary entertainment spending than it did previously.
Producers are adjusting, if not resolving, the issue. Proven brand revivals—shows with notoriety that lessen the marketing burden—and star-driven short runs of plays rather than musicals, which are much less expensive to produce and can be profitable without requiring the same size of audience, are now the safest investments. In order to lower risk, international tryouts—testing works in London or abroad prior to committing to a full Broadway capitalization—have also grown in popularity. Although none of these strategies are novel, their current dominance in producer strategy is a direct result of how challenging the economics of new musical production have become.
